## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by highβdose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre
β¦ LIBER β¦
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma
β Scribed by van Imhoff, G W; van der Holt, B; MacKenzie, M A; Ossenkoppele, G J; Wijermans, P W; Kramer, M H H; van 't Veer, M B; Schouten, H C; van Marwijk Kooy, M; van Oers, M H J
- Book ID
- 110056255
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 128 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Chemotherapy with rituximab followed by
β
Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail;
π
Article
π
2005
π
John Wiley and Sons
π
English
β 122 KB
Failure of a single cycle of high dose c
β
Taner Demirer; C. Dean Buckner; Kathy Lilleby; Charles Weaver; Kevin Longin; Fre
π
Article
π
1994
π
John Wiley and Sons
π
English
β 688 KB
Long-term remission in a patient with he
β
Zaher K. Otrock; Hassan A. Hatoum; Ziad M. Salem; Ayman Tawil; Rami A. Mahfouz;
π
Article
π
2008
π
Springer
π
English
β 164 KB
Imatinib interim therapy between chemoth
β
Shin, H-J; Chung, J S; Cho, G J
π
Article
π
2005
π
Nature Publishing Group
π
English
β 92 KB
High-dose therapy and autologous periphe
β
Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia PraticΓ²; Caterina Ste
π
Article
π
2006
π
John Wiley and Sons
π
English
β 240 KB
π 2 views
## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplantβrelated mortality. We evaluated the combination of highβdose therapy and autologous peripheral blood stem cel